Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001004878-16-000344
Filing Date
2016-01-15
Accepted
2016-01-15 16:48:16
Documents
5
Period of Report
2016-01-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K AMEND RE SALE TO DE CLARA TRUST form8kamd101declarasale1-16.txt 8-K/A 3808
2 EXH. 5 - LEGAL OPINION form8kamd101ex51-16.txt EX-5 3089
3 EXH. 10(FFF) - DE CLARA TRUST SUB AGREE form8kamd101ex10fff1-16.txt EX-10 8048
4 EXH. 10(GGG) - SERIES X WARRANT form8kamd101ex10ggg1-16.txt EX-10 38550
5 EXH. 23 - H&H CONSENT form8kamd101ex231-16.txt EX-23 895
  Complete submission text file 0001004878-16-000344.txt   55617
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K/A | Act: 34 | File No.: 001-11889 | Film No.: 161345933
SIC: 2836 Biological Products, (No Diagnostic Substances)